Palisade Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Palisade Bio, Inc. (PALI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents9.8212.4312.3810.500.71
Short-Term Investments0.000.000.000.000.02
Cash & Short-Term Investments9.8212.4312.3810.500.73
Accounts Receivable0.020.151.440.150.06
Inventory0.000.000.000.000.00
Other Current Assets0.650.640.800.860.07
Total Current Assets10.4913.3314.7311.510.90
Non-Current Assets
Property, Plant & Equipment (Net)0.090.210.310.110.28
Long-Term Investments0.030.000.000.000.00
Other Non-Current Assets0.270.040.720.030.03
Total Non-Current Assets0.390.721.031.010.00
Total Assets10.8814.0515.7612.513.02
Current Liabilities
Accounts Payable1.110.841.761.522.54
Short-Term Debt0.170.160.090.091.05
Current Portion of Long-Term Debt0.080.160.090.091.05
Accrued Liabilities1.960.551.060.274.33
Other Current Liabilities1.960.780.490.510.00
Total Current Liabilities3.242.593.012.508.08
Non-Current Liabilities
Long-Term Debt0.000.090.210.090.09
Other Non-Current Liabilities0.150.060.062.651.83
Total Non-Current Liabilities0.150.150.272.650.00
Total Liabilities3.392.743.285.1510.12
Stockholders' Equity
Common Stock0.030.010.030.000.03
Retained Earnings-135.94-121.51-109.19-94.64-68.03
Additional Paid-in Capital143.41132.81121.64102.000.00
Shares Outstanding2.970.820.400.220.00
Total Stockholders' Equity7.4911.3112.487.37-7.10
Total Liabilities & Equity10.8814.0515.7612.510.00